Innate immune functions of immature neutrophils in patients with sepsis and severe systemic inflammatory response syndrome

Critical Care Medicine

Volumn 41, Issue 3, 2013, Pages 820-832

  Drifte, Geneviève ^a,b   Dunn Siegrist, Irène ^a,b   Tissières, Pierre ^a,b   Pugin, Jérôme ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Chemotaxis; Cytokines; Neutrophils; Phagocytosis; Sepsis; Toll like receptors

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CD16 ANTIGEN; CHEMOKINE RECEPTOR CXCR2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; PROCALCITONIN; PROTEIN MD 2; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; BACTERICIDAL ACTIVITY; CELL MATURATION; CELL SURVIVAL; CELL VIABILITY; CHEMOTAXIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ESCHERICHIA COLI; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; INTENSIVE CARE UNIT; LEUKOCYTE MIGRATION; MALE; NEUTROPHIL; OBSERVATIONAL STUDY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SEPSIS; STAPHYLOCOCCUS AUREUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; AGED, 80 AND OVER; BLOOD BACTERICIDAL ACTIVITY; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; FEMALE; HUMANS; IMMUNITY, INNATE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NEUTROPHILS; PHAGOCYTOSIS; PROSPECTIVE STUDIES; REACTIVE OXYGEN SPECIES; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874934874     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318274647d     Document Type: Article

References (45)

1. Salomão R, Martins PS, Brunialti MK, et al.: TLR signaling pathway in patients with sepsis. Shock 2008; 30(Suppl 1):73-77
2. Alberti C, Brun-Buisson C, Burchardi H, et al.: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28:108-121
3. Martin GS, Mannino DM, Eaton S, et al.: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554
4. Cohen J: The immunopathogenesis of sepsis. Nature 2002; 420: 885-891
5. Smith J A: Neutrophils, host defense, and inflammation: A double-edged sword. J Leukoc Biol 1994; 56:672-686
6. Lange M, Bröking K, van Aken H, et al: [Role of ketamine in sepsis and systemic inflammatory response syndrome]. Anaesthesist 2006; 55:883-891
7. Orr Y, Taylor JM, Bannon PG, et al.: Circulating CD10-/CD16low neutrophils provide a quantitative index of active bone marrow neutrophil release. Br J Haematol 2005; 131:508-519
8. Brown CC, Malech HL, Gallin J I: Intravenous endotoxin recruits a distinct subset of human neutrophils, defined by monoclonal antibody 31D8, from bone marrow to the peripheral circulation. Cell Immunol 1989; 123:294-306
9. Seligmann B, Malech HL, Melnick DA, et al.: An antibody binding to human neutrophils demonstrates antigenic heterogeneity detected early in myeloid maturation which correlates with functional heterogeneity of mature neutrophils. J Immunol 1985; 135:2647-2653
10. Krause PJ, Todd MB, Hancock WW, et al.: The role of cellular maturation in neutrophil heterogeneity. Blood 1990; 76:1639-1646
11. Spiekermann K, Roesler J, Elsner J, et al.: Identification of the antigen recognized by the monoclonal antibody 31D8. Exp Hematol 1996; 24:453-458
12. Pillay J, Ramakers BP, Kamp VM, et al.: Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia. J Leukoc Biol 2010; 88:211-220
13. Bone RC, Balk RA, Cerra FB, et al.: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
14. Muckart DJ, Bhagwanjee S: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 1997; 25:1789-1795
15. van den Akker EL, Baan CC, van den Berg B, et al.: Ficoll-separated mononuclear cells from sepsis patients are contaminated with granulocytes. Intensive Care Med 2008; 34:912-916
16. Rämet M, Manfruelli P, Pearson A, et al.: Functional genomic analysis of phagocytosis and identification of a Drosophila receptor for E. coli. Nature 2002; 416:644-648
17. Bass DA, Parce JW, Dechatelet LR, et al.: Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation. J Immunol 1983; 130:1910-1917
18. Cassidy RA, Burleson DG, Delgado AV, et al.: Effects of heme proteins on nitric oxide levels and cell viability in isolated PMNs: A mechanism of toxicity. J Leukoc Biol 2000; 67:357-368
19. Bo L, Wang F, Zhu J, et al.: Granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony stimulating factor (GMCSF) for sepsis: A meta-analysis. Crit Care 2011; 15:R58
20. Biffl WL, Moore EE, Zallen G, et al.: Neutrophils are primed for cytotoxicity and resist apoptosis in injured patients at risk for multiple organ failure. Surgery 1999; 126:198-202
21. Taneja R, Parodo J, Jia SH, et al.: Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit Care Med 2004; 32: 1460-1469
22. Keel M, Ungethüm U, Steckholzer U, et al.: Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 1997; 90:3356-3363
23. Jimenez MF, Watson RW, Parodo J, et al.: Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg 1997; 132:1263-9; discussion 1269
24. Brach MA, deVos S, Gruss HJ, et al.: Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colonystimulating factor is caused by inhibition of programmed cell death. Blood 1992; 80:2920-2924
25. Lee A, Whyte MK, Haslett C: Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993; 54:283-288
26. Glasser L, Fiederlein R L: Functional differentiation of normal human neutrophils. Blood 1987; 69:937-944
27. Härter L, Mica L, Stocker R, et al.: Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 2004; 22: 403-409
28. Bone R C: Sepsis, sepsis syndrome, and the systemic inflammatory response syndrome (SIRS). Gulliver in Laputa. JAMA 1995; 273: 155-156
29. Pugin J, Stern-Voeffray S, Daubeuf B, et al.: Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock. Blood 2004; 104:4071-4079
30. Tissières P, Ochoda A, Dunn-Siegrist I, et al.: Innate immune deficiency of extremely premature neonates can be reversed by interferon-γ. PLoS ONE 2012; 7:e32863
31. Tissières P, Dunn-Siegrist I, Schäppi M, et al.: Soluble MD-2 is an acutephase protein and an opsonin for Gram-negative bacteria. Blood 2008; 111:2122-2131
32. Lichtman MA, Weed R I: Alteration of the cell periphery during granulocyte maturation: Relationship to cell function. Blood 1972; 39:301-316
33. van Eeden SF, Kitagawa Y, Klut ME, et al.: Polymorphonuclear leukocytes released from the bone marrow preferentially sequester in lung microvessels. Microcirculation 1997; 4:369-380
34. Taneja R, Sharma AP, Hallett MB, et al.: Immature circulating neutrophils in sepsis have impaired phagocytosis and calcium signaling. Shock 2008; 30:618-622
35. Murphey ED, Fang G, Sherwood E R: Endotoxin pretreatment improves bacterial clearance and decreases mortality in mice challenged with Staphylococcus aureus. Shock 2008; 29:512-518
36. Shi DW, Zhang J, Jiang HN, et al.: LPS pretreatment ameliorates multiple organ injuries and improves survival in a murine model of polymicrobial sepsis. Inflamm Res 2011; 60:841-849
37. Holtfreter S, Kolata J, Bröker B M: Towards the immune proteome of Staphylococcus aureus - The anti-S. aureus antibody response. Int J Med Microbiol 2010; 300:176-192
38. Marois L, Paré G, Vaillancourt M, et al.: Fc gammaRIIIb triggers raft-dependent calcium influx in IgG-mediated responses in human neutrophils. J Biol Chem 2011; 286:3509-3519
39. Brinkmann V, Reichard U, Goosmann C, et al.: Neutrophil extracellular traps kill bacteria. Science 2004; 303:1532-1535
40. Fialkow L, Wang Y, Downey G P: Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 2007; 42:153-164
41. Wenisch C, Fladerer P, Patruta S, et al.: Assessment of neutrophil function in patients with septic shock: Comparison of methods. Clin Diagn Lab Immunol 2001; 8:178-180
42. Voyich JM, Braughton KR, Sturdevant DE, et al.: Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005; 175:3907-3919
43. Fumeaux T, Dufour J, Stern S, et al.: Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines. Intensive Care Med 2004; 30:2028-2037
44. Opal SM, Girard TD, Ely E W: The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis 2005; 41(Suppl 7):S504-S512
45. Munford RS, Pugin J: Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001; 163:316-321